Therapy News and Research

RSS

Sumner M. Redstone donates $24M to Keck School of Medicine of USC to support cancer research

The Keck School of Medicine of the University of Southern California has announced a $24 million charitable gift from media executive and philanthropist Sumner M. Redstone. The multi-million dollar gift will support cancer research directed by renowned oncologist David Agus, M.D., professor of medicine at the Keck School of Medicine of USC and director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center.

16 Jul 2010

Early HIV treatment reduces death, likelihood of TB, study finds

"Early treatment for HIV cuts patients' risk of death by about 75 percent," according to a study conducted in Haiti and published Thursday in the New England Journal of Medicine, Bloomberg Businessweek reports. The study also demonstrated that "early antiretroviral treatment reduces the likelihood of tuberculosis, a leading cause of death among HIV patients, by 50 percent," the news service writes (Aquino, 7/14).

16 Jul 2010

New findings on macrophage activation can facilitate development of early diagnosis tools

Immune system cells called macrophages spring into action to surround and destroy threats such as viruses or cancer cells. But sometimes the would-be protective response leads to persistent inflammation, which, in turn, can cause disease.Scientists don't know exactly how macrophages cross the line from being good cops to bad cops, but researchers at the University of Florida recently unearthed several clues about the mechanisms involved. Through the lens of two inflammation-related diseases, HIV and rheumatoid arthritis, they identified changes in specific proteins linked to the action of macrophages, white blood cells that are key to the body's natural defenses.

16 Jul 2010

Cubist Pharmaceuticals total net revenues for second-quarter 2010 increase 29%

Cubist Pharmaceuticals, Inc. today announced results for the second quarter ended June 30, 2010.

16 Jul 2010

Elusys, Lonza partner for commercial production of Anthim antibody for inhaled anthrax treatment

Elusys Therapeutics and Lonza today announced an agreement for the scale-up and commercial production of Anthim, a therapeutic monoclonal antibody in late-stage development for the treatment of inhaled anthrax. Under the new contract, Lonza will provide process scale-up, technology transfer, validation, and commercial manufacturing at one of its facilities in the USA. The manufacturing process for Anthim was optimized for full scale production by Lonza under a separate agreement announced in 2009.

16 Jul 2010

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

This week, nearly 4,000 scientists from around the world gathered to report and discuss the latest advances in research on treatments, risk factors, and diagnosis for the health epidemic of the 21st century – Alzheimer's disease – at the Alzheimer's Association's 2010 International Conference on Alzheimer's Disease in Honolulu.

15 Jul 2010

Shrink Nanotechnologies files patent applications for CellAlign advanced tissue engineering technology

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign™, have been filed.

15 Jul 2010

Premier, Xoft execute group purchasing contract

Premier Inc., an alliance of more than 2,300 U.S. hospitals and 67,000-plus other healthcare sites working together to achieve high quality, cost-effective care, and Xoft, Inc., the leading provider of FDA-cleared Electronic Brachytherapy Systems, announced the execution of a group purchasing contract. Xoft was awarded an exclusive three-year contract for brachytherapy systems with Premier Purchasing Partners L.P., the group purchasing unit of Premier, Inc.

15 Jul 2010

Top treatments and tests for hair loss

August is National Hair Loss Awareness Month and it's an important time for men and women to talk to their doctors about the newest tests and treatments available to help them. Over 100 million Americans are affected - including 60 million men and 40 million women.

15 Jul 2010

NIH awards MacroGenics $9.8 million grant for three projects

MacroGenics, Inc, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that the National Institutes of Health (NIH) has awarded the company three new grants representing total funding of $9.8 million.

15 Jul 2010

IBM dedicates $100 million for global initiative to improve healthcare quality and costs

IBM today announced plans to enlist some of the company's leading scientists and technologists to help medical practitioners and insurance companies provide high-quality, evidence-based care to patients. As part of this initiative, IBM is collaborating with clinicians in medical institutions and hiring medical doctors to work alongside its researchers to develop new technologies, scientific advancements and business processes for healthcare and insurance providers.

15 Jul 2010

New drug launches for HCV in the Philippines to increase market earned revenues to $4.5 billion by 2017

Efforts to raise disease awareness in the Philippines have increased the number of cases and patient pool available for hepatitis C treatment. Screening and detection efforts by the Red Cross as well as growing awareness in the Philippines have been largely responsible for the rise in the number of diagnosed cases. These campaigns have encouraged people, mostly from the urban areas, to opt for physical examinations that enable the detection of hepatitis C.

15 Jul 2010

Scientists comment on two clinical trials that use Rituximab to treat small-vessel vasculitis

Two UNC School of Medicine faculty authored an editorial in the July 15, 2010 New England Journal of Medicine commenting on results from two clinical trials using the drug Rituximab to treat small-vessel vasculitis, a rare autoimmune disease.

15 Jul 2010

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

After two days of hearings, an advisory committee to the U.S. Food and Drug Administration (FDA) recommended that the FDA allow the type 2 diabetes drug rosiglitazone (brand name, Avandia), to stay on the market, but with most committee members suggesting that the label be revised to include increased warnings. Rosiglitazone is one in a class of drugs called thiazolidinediones (TZDs), used to treat type 2 diabetes.

15 Jul 2010

ConvaTec provides support to develop guidelines for NPWT

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that it has provided support for the development of guidelines for the appropriate use of negative pressure wound therapy in the spectrum of wound healing. Unique to these guidelines are recommendations for integrating NPWT into a comprehensive plan of care that includes moist wound healing dressings and other treatment modalities.

15 Jul 2010

Kidney Cancer Canada applauds Ontario for granting coverage for RCC therapy TORISEL

Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.

15 Jul 2010

MD Buyline identifies top emerging technologies with highest impact

This release will explain how these important technologies encourage high utilization rates across multiple service lines, bringing value to hospitals. Reimbursement changes and hospital structure enable technology purchases to generate a sequence of changes throughout service lines and dramatically impact the bottom line.

15 Jul 2010

IBM and Peking University People's Hospital build evidence-based patient centric care system

IBM and Peking University People's Hospital have built an evidence-based patient centric care (ePC3) system to enable cooperation and resource sharing among medical services providers for improved patient care.

15 Jul 2010

Keck School of Medicine receives grant for research on biomarker impact on breast cancer screening

Researchers at the Keck School of Medicine of the University of Southern California (USC) will test whether a set of blood-based biomarkers can assist mammography in the early detection of breast cancer with a $180,000 grant announced today from Susan G. Komen for the Cure®. The grant will fund research into whether specific biomarkers, or minute substances in the blood, can effectively distinguish breast cancer patients from their healthy counterparts and whether an inexpensive, less invasive screening strategy can be developed based on this approach.

15 Jul 2010

SWCRF/Emerald Foundation Global Collaborative Grant to fund critical cancer research

The leukemia stem cell-the root cause of all acute leukemias- represents a small population of cells in patients that are difficult to eliminate with standard treatments available today. Though current chemotherapy can produce temporary remission in leukemia survivors, they remain at risk of experiencing a recurrence and dying from the disease.

15 Jul 2010

Therapy News and Research

Sumner M. Redstone donates $24M to Keck School of Medicine of USC to support cancer research

Early HIV treatment reduces death, likelihood of TB, study finds

New findings on macrophage activation can facilitate development of early diagnosis tools

Cubist Pharmaceuticals total net revenues for second-quarter 2010 increase 29%

Elusys, Lonza partner for commercial production of Anthim antibody for inhaled anthrax treatment

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

Shrink Nanotechnologies files patent applications for CellAlign advanced tissue engineering technology

Premier, Xoft execute group purchasing contract

Top treatments and tests for hair loss

NIH awards MacroGenics $9.8 million grant for three projects

IBM dedicates $100 million for global initiative to improve healthcare quality and costs

New drug launches for HCV in the Philippines to increase market earned revenues to $4.5 billion by 2017

Scientists comment on two clinical trials that use Rituximab to treat small-vessel vasculitis

American Heart Association comments on FDA advisory committee's rosiglitazone recommendations

ConvaTec provides support to develop guidelines for NPWT

Kidney Cancer Canada applauds Ontario for granting coverage for RCC therapy TORISEL

MD Buyline identifies top emerging technologies with highest impact

IBM and Peking University People's Hospital build evidence-based patient centric care system

Keck School of Medicine receives grant for research on biomarker impact on breast cancer screening

SWCRF/Emerald Foundation Global Collaborative Grant to fund critical cancer research

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News